CL
50
3
BF.B
35
2
CME
61
2
TEL
60
2
BK
61
3
HSY
34
3
AME
50
3
ZION
52
3
GWW
51
3
ALLE
25
4
IPG
42
2
ZBH
71
3
HPQ
57
2
GE
64
4
DOV
50
2
PEP
36
3
EQIX
59
2
F
40
2
MMC
50
4
AIZ
66
3
CL
50
3
BF.B
35
2
CME
61
2
TEL
60
2
BK
61
3
HSY
34
3
AME
50
3
ZION
52
3
GWW
51
3
ALLE
25
4
IPG
42
2
ZBH
71
3
HPQ
57
2
GE
64
4
DOV
50
2
PEP
36
3
EQIX
59
2
F
40
2
MMC
50
4
AIZ
66
3
Financhill
Back

Kazia Therapeutics 10K Form

Sell
12

KZIA
Kazia Therapeutics

Last Price:
$2.95
Seasonality Move:
9.64%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KZIA News And Ratings

See the #1 stock for the next 7 days that we like better than KZIA

KZIA Financial Statistics

Sales & Book Value

Annual Sales: $1.5M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $-2.01
Price / Book: 2.76

Profitability

EPS (TTM): -6.66830
Net Income (TTM): $-17.6M
Gross Margin: $1.6M
Return on Equity: -1083.16%
Return on Assets: -106.28%

Kazia Therapeutics Earnings Forecast

Key Kazia Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 12 years for KZIA is 100.00%.
  • The Selling, General & Administrative Expenses for KZIA have been equal to 587.65% of Gross Profit Margin.
  • The Research & Development expenses have been 753.03% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 26 years have been positive in 14 years.

Kazia Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: KZIA
CUSIP: 48669G
Website: kaziatherapeutics.com

Debt

Debt-to-Equity Ratio: -0.06
Current Ratio: 0.24
Quick Ratio: 0.07

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

KZIA Technical Analysis vs Fundamental Analysis

Sell
12
Kazia Therapeutics (KZIA) is a Sell

Is Kazia Therapeutics a Buy or a Sell?